Title:
MONITERING METHOD, REAGENT, AND TEST KIT FOR MONITORING NCA-BT IN BLOOD SAMPLE OF BREAST CANCER PATIENT.
Document Type and Number:
Japanese Patent JP3258407
Kind Code:
B2
Abstract:
PURPOSE: To monitor the progress or stage of the disease of a patient by measuring the NCA-BT level of a blood sample by performing a series of specific immunoassay for a certain period.
CONSTITUTION: Of the nonspecific cross-reacting antigens (NCA) in blood, the change of the NCA-BT level becomes a means for monitoring the progress of the disease of a breast cancer patient. The increase of the NCA-BT level in blood measured by performing a series of specific immunoassay over a certain period indicates worsening states in a significant number of patients and, on the other hand, the decrease of the NCA-BT level in blood indicates improved state in such patients. The measurement of the NCA-BT level is performed by performing sandwich immunoassay using two reagents for antibody of one reagent which is specific to BCA-BT and another reagent which can be coupled specifically or nonspecifically with NCA-BT.
Inventors:
James J. Erting
Thomas Earl Burnett
Thomas Earl Burnett
Application Number:
JP35469492A
Publication Date:
February 18, 2002
Filing Date:
December 17, 1992
Export Citation:
Assignee:
Bayer Corporation
International Classes:
C12P21/08; G01N33/53; G01N33/535; G01N33/574; G01N33/577; C12N15/02; C12R1/91; (IPC1-7): G01N33/577; C12N15/02; G01N33/53; G01N33/535; G01N33/574
Domestic Patent References:
| JP6429400A | ||||
| JP1120289A |
Attorney, Agent or Firm:
Hajime Tsukuni (1 person outside)